- New
-
Topics
- All Categories
- Metaphysics and Epistemology
- Value Theory
- Science, Logic, and Mathematics
- Science, Logic, and Mathematics
- Logic and Philosophy of Logic
- Philosophy of Biology
- Philosophy of Cognitive Science
- Philosophy of Computing and Information
- Philosophy of Mathematics
- Philosophy of Physical Science
- Philosophy of Social Science
- Philosophy of Probability
- General Philosophy of Science
- Philosophy of Science, Misc
- History of Western Philosophy
- Philosophical Traditions
- Philosophy, Misc
- Other Academic Areas
- Journals
- Submit material
- More
INTRODUCTION: Public Sector and Non-Profit Contributions to Drug Development — Historical Scope, Opportunities, and Challenges
Journal of Law, Medicine and Ethics 49 (1):6-9 (2021)
Abstract
This article has no associated abstract. (fix it)Other Versions
No versions found
My notes
Similar books and articles
A Non-Profit Approach to Address Foreign Dependence of Generic Drugs.Dan Liljenquist, Ge Bai, Ameet Sarpatwari & Gerard F. Anderson - 2021 - Journal of Law, Medicine and Ethics 49 (1):30-33.
“A Most Equitable Drug”: How the Clinical Studies of Convalescent Plasma as a Treatment for SARS-CoV-2 Might Usefully Inform Post-Pandemic Public Sector Approaches to Drug Development.Quinn Grundy, Chantal Campbell, Ridwaanah Ali, Matthew Herder & Kelly Holloway - 2024 - Journal of Law, Medicine and Ethics 52 (1):80-97.
International Challenges and Opportunities in Health.John R. Evans - 1993 - Journal of Law, Medicine and Ethics 21 (1):10-15.
Use of Public Research and Manufacturing Enterprises to Lower Prescription Drug Prices and Increase Innovation.Alex Moss, Dana Brown & S. Sean Tu - 2024 - Journal of Law, Medicine and Ethics 52 (3):750-754.
The Government and Pharmaceutical Innovation: Looking Back and Looking Ahead.Bhaven N. Sampat - 2021 - Journal of Law, Medicine and Ethics 49 (1):10-18.
Interdisciplinary Contributions to Public Health Law.Susan Allan, Sana Loue, Howard Markel, Charity Scott & Martin P. Wasserman - 2004 - Journal of Law, Medicine and Ethics 32 (S4):92-96.
Opportunities and Challenges of Generic Pre-Exposure Prophylaxis Drugs for HIV.Jeromie Ballreich, Timothy Levengood & Rena M. Conti - 2022 - Journal of Law, Medicine and Ethics 50 (S1):32-39.
Waging a War on Drug Users: An Alternative Public Health Vision.Larry Gostin - 1990 - Journal of Law, Medicine and Ethics 18 (4):385-394.
Germany.Jonathan Ruetz & Kirstin Hallmann - 2024 - In Kirstin Hallmann, Suvi Heikkinen & Hanna Vehmas (eds.), Management of Sport Organizations at the Crossroad of Responsibility and Sustainability: Perceptions, Practices, and Prospects Around the World. Springer Nature Switzerland. pp. 85-97.
An HMO grievance committee: Ethical challenges and opportunities for the organization. [REVIEW]Leonard Weber - 1998 - HEC Forum 10 (2):201-212.
Analytics
Added to PP
2021-04-22
Downloads
29 (#773,133)
6 months
4 (#1,246,940)
2021-04-22
Downloads
29 (#773,133)
6 months
4 (#1,246,940)
Historical graph of downloads
References found in this work
The Future of the Pharmaceutical Industry: Beyond Government-Granted Monopolies.Dean Baker - 2021 - Journal of Law, Medicine and Ethics 49 (1):25-29.
A Market Shaping Approach for the Biopharmaceutical Industry: Governing Innovation Towards the Public Interest.Mariana Mazzucato & Henry Lishi Li - 2021 - Journal of Law, Medicine and Ethics 49 (1):39-49.
Opportunities and Challenges in Translational Research: The Development of Photodynamic Therapy and Anti-Vascular Endothelial Growth Factor Drugs.Christina Kaiser Marko & Joan W. Miller - 2021 - Journal of Law, Medicine and Ethics 49 (1):19-24.
Realizing Public Rights Through Government Patent Use.Amy Kapczynski - 2021 - Journal of Law, Medicine and Ethics 49 (1):34-38.
The Government and Pharmaceutical Innovation: Looking Back and Looking Ahead.Bhaven N. Sampat - 2021 - Journal of Law, Medicine and Ethics 49 (1):10-18.
PhilPapers logo by Andrea Andrews and Meghan Driscoll.
This site uses cookies and Google Analytics (see our terms & conditions for details regarding the privacy implications). Use of this site is subject to terms & conditions.
All rights reserved by The PhilPapers Foundation
Server: philpapers-web-559df78dcc-45kst uwo